Detection of CD39 and a Highly Glycosylated Isoform of Soluble CD73 in the Plasma of Patients with Cervical Cancer: Correlation with Disease Progression
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Detection of CD39 and a Highly Glycosylated Isoform of Soluble CD73 in the Plasma of Patients with Cervical Cancer: Correlation with Disease Progression
Authors
Keywords
-
Journal
MEDIATORS OF INFLAMMATION
Volume 2020, Issue -, Pages 1-14
Publisher
Hindawi Limited
Online
2020-12-09
DOI
10.1155/2020/1678780
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Purinergic signaling and tumor microenvironment in cervical Cancer
- (2020) Marta Schmidt Pfaffenzeller et al. Purinergic Signalling
- Hydrolysis of ATP, ADP, and AMP is increased in blood plasma of prostate cancer patients
- (2019) Carla Fernanda Furtado Gardani et al. Purinergic Signalling
- Microvesicles expressing adenosinergic ectoenzymes and their potential role in modulating bone marrow infiltration by neuroblastoma cells
- (2019) Fabio Morandi et al. OncoImmunology
- Inhibition of the adenosinergic pathway: the indispensable part of oncological therapy in the future
- (2019) Yi Huang et al. Purinergic Signalling
- HPV-16 Infection Is Associated with a High Content of CD39 and CD73 Ectonucleotidases in Cervical Samples from Patients with CIN-1
- (2019) María de Lourdes Mora-García et al. MEDIATORS OF INFLAMMATION
- Adenosine Metabolism: Emerging Concepts for Cancer Therapy
- (2019) Detlev Boison et al. CANCER CELL
- Adenosine signaling and the immune system: When a lot could be too much
- (2018) Luca Antonioli et al. IMMUNOLOGY LETTERS
- Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence
- (2018) M.-N. Theodoraki et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Cervical cancer cells produce TGF-β1 through the CD73-adenosine pathway and maintain CD73 expression through the autocrine activity of TGF-β1
- (2018) Rosario García-Rocha et al. CYTOKINE
- The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
- (2017) Bertrand Allard et al. IMMUNOLOGICAL REVIEWS
- Evasion of host immune defenses by human papillomavirus
- (2017) Joseph A. Westrich et al. VIRUS RESEARCH
- Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions
- (2016) María de Lourdes Mora-García et al. Journal of Translational Medicine
- Exosome-Mediated Metastasis: From Epithelial–Mesenchymal Transition to Escape from Immunosurveillance
- (2016) Nicholas Syn et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Transforming growth factor-β1 in carcinogenesis, progression, and therapy in cervical cancer
- (2016) Haiyan Zhu et al. TUMOR BIOLOGY
- Alternative splicing of human NT5E in cirrhosis and hepatocellular carcinoma produces a negative regulator of ecto-5′-nucleotidase (CD73)
- (2014) Natasha T. Snider et al. MOLECULAR BIOLOGY OF THE CELL
- Purines, Purinergic Receptors, and Cancer
- (2012) F. Di Virgilio CANCER RESEARCH
- Cellular function and molecular structure of ecto-nucleotidases
- (2012) Herbert Zimmermann et al. Purinergic Signalling
- Crystal Structure of the Human Ecto-5′-Nucleotidase (CD73): Insights into the Regulation of Purinergic Signaling
- (2012) Karen Knapp et al. STRUCTURE
- Cancer Exosomes Express CD39 and CD73, Which Suppress T Cells through Adenosine Production
- (2011) A. Clayton et al. JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search